Zhongzhi Pharmaceutical Holdings Limited (3737.HK)
HKD 0.89
(-2.2%)
HKD 0.89
(-2.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.21 Billion CNY | 14.13% |
| 2022 | 1.06 Billion CNY | 0.57% |
| 2021 | 1.06 Billion CNY | 7.09% |
| 2020 | 991.08 Million CNY | 18.8% |
| 2019 | 834.23 Million CNY | 18.6% |
| 2018 | 703.42 Million CNY | 25.3% |
| 2017 | 561.38 Million CNY | 40.54% |
| 2016 | 399.43 Million CNY | 6.49% |
| 2015 | 375.07 Million CNY | 17.11% |
| 2014 | 320.27 Million CNY | 33.8% |
| 2013 | 239.37 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 627.04 Million CNY | 16.2% |
| 2023 Q2 | 674.96 Million CNY | 20.06% |
| 2023 FY | 1.21 Billion CNY | 14.13% |
| 2023 Q4 | 539.64 Million CNY | -20.05% |
| 2022 FY | 1.06 Billion CNY | 0.57% |
| 2022 Q2 | 505.18 Million CNY | -2.01% |
| 2022 Q4 | 562.16 Million CNY | 11.28% |
| 2021 FY | 1.06 Billion CNY | 7.09% |
| 2021 Q2 | 545.81 Million CNY | 2.42% |
| 2021 Q4 | 515.53 Million CNY | -5.55% |
| 2020 Q2 | 458.17 Million CNY | 3.76% |
| 2020 FY | 991.08 Million CNY | 18.8% |
| 2020 Q4 | 532.91 Million CNY | 16.31% |
| 2019 FY | 834.23 Million CNY | 18.6% |
| 2019 Q4 | 441.55 Million CNY | 12.45% |
| 2019 Q2 | 392.68 Million CNY | 8.88% |
| 2018 Q2 | 342.75 Million CNY | 11.17% |
| 2018 FY | 703.42 Million CNY | 25.3% |
| 2018 Q4 | 360.66 Million CNY | 5.23% |
| 2017 Q2 | 253.07 Million CNY | 25.49% |
| 2017 Q4 | 308.3 Million CNY | 21.82% |
| 2017 FY | 561.38 Million CNY | 40.54% |
| 2016 Q4 | 201.67 Million CNY | 1.98% |
| 2016 FY | 399.43 Million CNY | 6.49% |
| 2016 Q2 | 197.76 Million CNY | 8.04% |
| 2015 Q4 | 183.05 Million CNY | -4.67% |
| 2015 Q2 | 192.02 Million CNY | 15.58% |
| 2015 FY | 375.07 Million CNY | 17.11% |
| 2014 FY | 320.27 Million CNY | 33.8% |
| 2014 Q2 | 154.13 Million CNY | 92.51% |
| 2014 Q4 | 166.13 Million CNY | 7.79% |
| 2013 FY | 239.37 Million CNY | 0.0% |
| 2013 Q4 | 80.06 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -627.528% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 81.328% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -4132.75% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -208.537% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 3521.462% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -120.954% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | 20.863% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -158.469% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -462.318% |
| SSY Group Limited | 3.48 Billion HKD | 65.088% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -281.366% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -96.324% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 97.191% |